[ad_1]
The candidate vaccine from the American company Modern is 94.1% effective against Covid and 100% in severe cases. This was announced by the company, announcing the results of phase 3 tests in 196 cases. Hoy Moderna will apply to the US pharmaceutical authority FDA for an emergency use authorization and to the European Medicines Agency EMA for a conditional authorization.
The United States Drug Authority (FDA) Vaccine Committee is expected to meet on December 17 to review the efficacy and safety data of the company’s Covid candidate mRNA-1273 vaccine candidate Moderna. This was announced by the same company, specifying that the distribution of the vaccine in the US will take place immediately after an authorization for emergency use is granted.
The CEO: “Powerful New Tool”
This positive analysis confirms the ability of our vaccine to prevent Covid-19 with an effectiveness of 94.1% and, above all, the ability to prevent serious forms. We believe that our vaccine will provide a powerful new tool that could change the course of this pandemic and help prevent serious illness, hospitalizations, and deaths. This was stated by Stéphane Bancel, CEO of Moderna, when reporting the latest data from the phase 3 trial of the candidate vaccine. “We will submit an emergency use authorization request to the Food and Drug Administration today and continue to move forward with ongoing reviews that have already begun with various regulatory agencies around the world,” he adds. «I want to thank – adds Bancel – to the thousands of participants in our Phase 1, Phase 2 and Phase 3 studies, as well as the personnel of the clinical trial sites at the forefront of the fight against the virus. I would like again to thank our partners at Nih, Niaid, Barda and Operation Warp Speed who assisted us in the clinical development of mRna-1273. Finally, I want to thank the Moderna team and our suppliers and partners for their tireless work in the research, development and production of our vaccine.
Last Updated: Monday, November 30, 2020, 4:46 PM
© REPRODUCTION RESERVED
